Inflamalps is a company whose mission is to discover and develop novel medicines to treat inflammation with a focus on inflammatory diseases of the eye
14.08.2015
La start-up biotech Inflamalps lève 1.8 millions de francs (startupticker.ch)
17.04.2015
Nine hot start-ups, 400 visitors and Joe Jimenez (startupticker.ch)
08.08.2014
Inflamalps in-licenses drug candidate for the treatment of inflammatory diseases (startupticker.ch)
13.02.2012
Quatre nouvelles start-up dans l?Incubateur The Ark (startupticker.ch)
No milestones
No Jobs
No Awards
Website:
www.inflamalps.com
Headquarter:
Monthey
Foundation Date:
August 2012
Technology:
Sectors: